Dr Palomaki is Assistant Director of the Division of Medical Screening and Special Testing at Women & Infants Hospital of Rhode Island and Professor (Research) in the Department of Pathology and Laboratory Medicine, Alpert Medical School at Brown University. His interests are in the areas of evidence-based medicine and the formal evaluation of screening and diagnostic test implementation, especially in the areas of prenatal screening and genetics. He is a member of the College of American Pathologists Biochemical and Molecular Genetics Resource Committee, on the editorial board of the Journal of Medical Screening and has authored over 250 peer-reviewed papers in these areas.
| Hardy EJ, Palomaki GE, Sung CJ, Lambert-Messerlian GM. "Surveillance of SARS-CoV-2 Antibodies in Early 2020 among Rhode Island Pregnancies." Annals of clinical and laboratory science, vol. 52, no. 5, 2022, pp. 788-795. |
| Palomaki GE, Haddow JE. "Confusion between analytic validity and clinical validity." American Journal of Obstetrics and Gynecology, 2016. |
| Maredia H, Lambert-Messerlian GM, Palomaki GE, Viali S, Hawley NL, McGarvey ST. "Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population." Clinical Biochemistry, vol. 49, no. 10-11, 2016, pp. 782-6. |
| Haddow, James E., Craig, Wendy Y., Neveux, Louis M., Palomaki, Glenn E., Lambert-Messerlian, Geralyn, Malone, Fergal D., D’Alton, Mary E. "Free Thyroxine During Early Pregnancy and Risk for Gestational Diabetes." PLoS ONE, vol. 11, no. 2, 2016, pp. e0149065. |
| Richards CS, Palomaki GE, Hegde M. "Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1." Genet Med, 2016. |
| Palomaki, G. E., Ashwood, E. R., Weck, K. E. "A flawed challenge but valid recommendation: a response to Takoudes and Hamar." Ultrasound Obstet Gynecol, vol. 45, no. 1, 2015, pp. 117-117. |
| Haddow, James E., Neveux, Louis M., Palomaki, Glenn E., Lambert-Messerlian, Geralyn, Malone, Fergal D., D'Alton, Mary E. "An Inverse Relationship Between Weight and Free Thyroxine During Early Gestation Among Women Treated for Hypothyroidism." Thyroid, vol. 25, no. 8, 2015, pp. 949-953. |
| Palomaki, Glenn E., Kloza, E. M., Lambert-Messerlian, G. M., van den Boom, D., Ehric, M., Deciu, C., Bombard, A. T., Haddow, J. E. "Circulating Cell Free DNA Testing." Obstetrical & Gynecological Survey, vol. 70, no. 8, 2015, pp. 492-494. |
| Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., van den Boom, D., Ehrich, M., Deciu, C., Bombard, A. T., Haddow, J. E. "Circulating cell free DNA testing: are some test failures informative?." Prenat Diagn, vol. 35, no. 3, 2015, pp. 289-293. |
| Palomaki, Glenn E., Eklund, Elizabeth E., Neveux, Louis M., Lambert Messerlian, Geralyn M. "Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures." Prenat Diagn, vol. 35, no. 8, 2015, pp. 789-796. |
| Palomaki, Glenn E., Ashwood, Edward R., Best, Robert G., Lambert-Messerlian, Geralyn, Knight, George J. "Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States?." Genet Med, vol. 17, no. 11, 2015, pp. 897-900. |
| Palomaki GE, Haddow JE, Haddow HR, Salahuddin S, Geahchan C, Cerdeira AS, Verlohren S, Perschel FH, Horowitz G, Thadhani R, Karumanchi SA, Rana S. "Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia." Prenat Diagn, vol. 35, no. 4, 2015, pp. 386-93. |
| Lambert-Messerlian, Geralyn, Palomaki, Glenn E. "Prenatal serum screening markers may not require adjustment in former smokers." Prenat Diagn, vol. 35, no. 13, 2015, pp. 1371-1373. |
| Palomaki, G. E. "Screening for breast cancer by molecular testing for three founder mutations in the BRCA1 and BRCA2 genes among women of Ashkenazi Jewish heritage." Journal of medical screening, vol. 22, no. 3, 2015, pp. 109-111. |
| Grosse, Scott D., Palomaki, Glenn E., Mvundura, Mercy, Hampel, Heather. "The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates." Genet Med, vol. 17, no. 6, 2015, pp. 510-511. |
| Pinar H, Palomaki GE, Haddow HR, Rowles A, Torabi R. "Comparison of radiographic femur measurements in stillbirths and neonatal deaths to ultrasound measurements in ongoing pregnancies." Pediatric and Developmental Pathology, vol. 17, no. 2, 2014, pp. 107-11. |
| Palomaki GE, Lambert-Messerlian G. "Down syndrome screening: suitability of a WHO 5 standardized total hCG assay." Clinical Biochemistry, vol. 47, no. 7-8, 2014, pp. 629-31. |
| Kloza, Edward M., Haddow, Paula K., Halliday, Jacquelyn V., O’Brien, Barbara M., Lambert-Messerlian, Geralyn M., Palomaki, Glenn E. "Evaluation of Patient Education Materials: The Example of Circulating cell free DNA Testing for Aneuploidy." Journal of Genetic Counseling, vol. 24, no. 2, 2014, pp. 259-266. |
| Haddow JE, Craig WY, Neveux LM, Haddow HR, Palomaki GE, Lambert-Messerlian G, Malone FD, D'Alton ME, First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium. "Implications of High Free Thyroxine (FT4) concentrations in euthyroid pregnancies: the FaSTER trial." The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 6, 2014, pp. 2038-44. |
| Palomaki, Glenn E. "Is it time for BRCA1/2 mutation screening in the general adult population?: impact of population characteristics." Genet Med, vol. 17, no. 1, 2014, pp. 24-26. |
| Lambert-Messerlian G, Kloza EM, Williams J 3rd, Loucky J, O'Brien B, Wilkins-Haug L, Mahoney MJ, De Biasio P, Borrell A, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE. "Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies." Genet Med, vol. 16, no. 5, 2014, pp. 419-22. |
| O'Brien, Barbara M., Kloza, Edward M., Halliday, Jacquelyn V., Lambert-Messerlian, Geralyn M., Palomaki, Glenn E. "Maternal Plasma DNA Testing: Experience of Women Counseled at a Prenatal Diagnosis Center." Genetic Testing and Molecular Biomarkers, vol. 18, no. 10, 2014, pp. 665-669. |
| Lyon, Elaine, Schrijver, Iris, Weck, Karen E., Ferreira-Gonzalez, Andrea, Richards, C. Sue, Palomaki, Glenn E. "Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys." Genet Med, vol. 17, no. 3, 2014, pp. 219-225. |
| Tafe, Laura J., Datto, Michael B., Palomaki, Glenn E., Lacbawan, Felicitas L. "Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys." Genet Med, vol. 17, no. 1, 2014, pp. 58-62. |
| Lyon, E., Cockerill, F. R., Bale, S. J., Beadling, C., Bry, L., Hagenkord, J., Kulkarni, S., Press, R., Palomaki, G. E. "Next Generation Sequencing in Clinical Diagnostics: Experiences of Early Adopters." Clinical Chemistry, vol. 61, no. 1, 2014, pp. 41-49. |
| Feldman, Gerald L., Schrijver, Iris, Lyon, Elaine, Palomaki, Glenn E. "Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population." Genet Med, vol. 16, no. 9, 2014, pp. 695-702. |
| Richards CS, Palomaki GE, Lacbawan FL, Lyon E, Feldman GL, CAP/ACMG Biochemical and Molecular Genetics Resource Committee. "Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders." Genet Med, vol. 16, no. 1, 2014, pp. 25-32. |
| Lambert-Messerlian G, Eklund EE, Chien EK, Rosene-Montella K, Neveux LM, Haddow HR, Palomaki GE. "Use of first or second trimester serum markers, or both, to predict preeclampsia." Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, vol. 4, no. 4, 2014, pp. 271-278. |
| Ashwood ER, Palomaki GE. "A new era in noninvasive prenatal testing." New England Journal of Medicine, vol. 369, no. 22, 2013, pp. 2164. |
| Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N. "Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer." The Journal of Urology, vol. 190, no. 2, 2013, pp. 389-98. |
| Jensen TJ, Zwiefelhofer T, Tim RC, Džakula Ž, Kim SK, Mazloom AR, Zhu Z, Tynan J, Lu T, McLennan G, Palomaki GE, Canick JA, Oeth P, Deciu C, van den Boom D, Ehrich M. "High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma." PLoS ONE, vol. 8, no. 3, 2013, pp. e57381. |
| Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D'Alton ME, First And Second Trimester Risk Of Aneuploidy Faster Research Consortium. "Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy." Thyroid, vol. 23, no. 2, 2013, pp. 225-30. |
| Mazloom AR, Džakula Ž, Oeth P, Wang H, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard AT, Maeder M, McLennan G, Meschino W, Palomaki GE, Canick JA, Deciu C. "Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma." Prenat Diagn, vol. 33, no. 6, 2013, pp. 591-7. |
| Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. "Screening for down syndrome in the United States: results of surveys in 2011 and 2012." Archives of Pathology & Laboratory Medicine, vol. 137, no. 7, 2013, pp. 921-6. |
| Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. "The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies." Prenat Diagn, vol. 33, no. 7, 2013, pp. 667-74. |
| Palomaki GE, Melillo S, Marrone M, Douglas MP. "Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review." Genet Med, vol. 15, no. 8, 2013, pp. 600-11. |
| Palomaki GE, Richards CS. "Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey." Genet Med, vol. 14, no. 1, 2012, pp. 69-75. |
| Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA. "Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review." Genet Med, vol. 14, no. 1, 2012, pp. 39-50. |
| Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA. "DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study." Genet Med, vol. 14, no. 3, 2012, pp. 296-305. |
| Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE. "DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations." Prenat Diagn, vol. 32, no. 8, 2012, pp. 730-4. |
| Lambert-Messerlian GM, Palomaki GE, Eklund EE, Kloza EM, Neveux LM, Phipps MG, Canick JA. "Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening." Journal of medical screening, vol. 19, no. 4, 2012, pp. 164-70. |
| Lyon E, Gastier Foster J, Palomaki GE, Pratt VM, Reynolds K, Sábato MF, Scott SA, Vitazka P, working group of the Molecular Genetics Subcommittee on behalf of the American College of Medical Genetics and Genomics ACMG) Laboratory Quality Assurance Committee. "Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy." Genet Med, vol. 14, no. 12, 2012, pp. 990-1000. |
| Canick JA, Palomaki GE. "Maternal plasma DNA: a major step forward in prenatal testing." Journal of medical screening, vol. 19, no. 2, 2012, pp. 57-9. |
| Craig WY, Allan WC, Kloza EM, Pulkkinen AJ, Waisbren S, Spratt DI, Palomaki GE, Neveux LM, Haddow JE. "Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years." The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 1, 2012, pp. E22-8. |
| Sprawka N, Lambert-Messerlian G, Palomaki GE, Eklund EE, Canick JA. "Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes." Prenat Diagn, vol. 31, no. 3, 2011, pp. 282-5. |
| Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA. "DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study." Genet Med, vol. 13, no. 11, 2011, pp. 913-20. |
| Craig WY, Palomaki G, Roberson M, Haddow JE. "Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester." Prenat Diagn, vol. 31, no. 6, 2011, pp. 616-8. |
| Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA. "Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters." Prenat Diagn, vol. 31, no. 6, 2011, pp. 583-8. |
| Devaney SA, Palomaki GE, Scott JA, Bianchi DW. "Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis." JAMA, vol. 306, no. 6, 2011, pp. 627-36. |
| Haddow JE, Palomaki GE. "Screening to detect Lynch syndrome and prevent hereditary cancers in relatives." Journal of medical screening, vol. 18, no. 4, 2011, pp. 167-8. |
| Haddow JE, Neveux LM, Palomaki GE, Lambert-Messerlian G, Canick JA, Grenache DG, Lu J. "The relationship between PTH and 25-hydroxy vitamin D early in pregnancy." Clinical endocrinology, vol. 75, no. 3, 2011, pp. 309-14. |
| Haddow JE, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME, First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium. "Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption." Obstetrics and gynecology, vol. 117, no. 2 Pt 1, 2011, pp. 287-92. |
| Palomaki GE, Melillo S, Bradley LA. "Association between 9p21 genomic markers and heart disease: a meta-analysis." JAMA, vol. 303, no. 7, 2010, pp. 648-56. |
| Lambert-Messerlian G, Palomaki GE, Canick JA. "Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access(®) platform: suitability for use in first trimester Down's syndrome screening." Journal of medical screening, vol. 17, no. 3, 2010, pp. 109-13. |
| Palomaki GE, Knight GJ, Lambert-Messerlian G, Canick JA, Haddow JE. "Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndrome." Archives of Pathology & Laboratory Medicine, vol. 134, no. 11, 2010, pp. 1685-91. |
| Craig WY, Roberson M, Palomaki GE, Shackleton CH, Marcos J, Haddow JE. "Prevalence of steroid sulfatase deficiency in California according to race and ethnicity." Prenat Diagn, vol. 30, no. 9, 2010, pp. 893-8. |
| MacRae AR, Chodirker BN, Davies GA, Palomaki GE, Knight GJ, Minett J, Kavsak PA, Toi A, Chitayat D, Van Caeseele PG. "Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study." Prenat Diagn, vol. 30, no. 5, 2010, pp. 459-66. |
| Mvundura M, Grosse SD, Hampel H, Palomaki GE. "The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer." Genet Med, vol. 12, no. 2, 2010, pp. 93-104. |
| Haddow JE, Cleary-Goldman J, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME, First- and Second-Trimester Risk of Aneuploidy (FaSTER) Research Consortium. "Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery." Obstetrics and gynecology, vol. 116, no. 1, 2010, pp. 58-62. |
| Palomaki GE, Melillo S, Neveux L, Douglas MP, Dotson WD, Janssens AC, Balkite EA, Bradley LA. "Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies--a targeted evidence-based review." Genet Med, vol. 12, no. 12, 2010, pp. 772-84. |
| Lambert-Messerlian G, Palomaki GE, Canick JA. "Adjustment of serum markers in first trimester screening." Journal of medical screening, vol. 16, no. 2, 2009, pp. 102-3. |
| Palomaki GE, Bradley LA, Douglas MP, Kolor K, Dotson WD. "Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review." Genet Med, vol. 11, no. 1, 2009, pp. 21-34. |
| Lambert-Messerlian GM, Palomaki GE, Neveux LM, Chien E, Friedman A, Rosene-Montella K, Hayes M, Canick JA. "Early onset preeclampsia and second trimester serum markers." Prenat Diagn, vol. 29, no. 12, 2009, pp. 1109-17. |
| Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. "EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome." Genet Med, vol. 11, no. 1, 2009, pp. 42-65. |
| de la Chapelle A, Palomaki G, Hampel H. "Identifying Lynch syndrome." International Journal of Cancer, vol. 125, no. 6, 2009, pp. 1492-3. |
| Marcos J, Craig WY, Palomaki GE, Kloza EM, Haddow JE, Roberson M, Bradley LA, Shackleton CH. "Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies." Prenat Diagn, vol. 29, no. 8, 2009, pp. 771-80. |
| Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE, ACMG Laboratory Quality Assurance Committee. "Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements." Genet Med, vol. 11, no. 9, 2009, pp. 669-81. |
| Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO, EGAPP Working Group. "The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group." Genet Med, vol. 11, no. 1, 2009, pp. 3-14. |
| Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, Macrae AR, Jaffe AS. "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes." Clinica chimica acta; international journal of clinical chemistry, vol. 387, no. 1-2, 2008, pp. 133-8. |
| McClain MR, Palomaki GE, Piper M, Haddow JE. "A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding." Genet Med, vol. 10, no. 2, 2008, pp. 89-98. |
| Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME, FaSTER Research Consortium. "First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study." American Journal of Obstetrics and Gynecology, vol. 199, no. 1, 2008, pp. 62.e1-6. |
| Lambert-Messerlian GM, Palomaki GE, Canick JA. "Inhibin A measurement using an automated assay platform." Prenat Diagn, vol. 28, no. 5, 2008, pp. 399-403. |
| Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. "Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?." Clinical Chemistry, vol. 54, no. 4, 2008, pp. 747-51. |
| Palomaki GE, Neveux LM, Donnenfeld A, Lee JE, McDowell G, Canick JA, Summers A, Lambert-Messerlian G, Kellner LH, Zebelman A, Haddow JE. "Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective." Genet Med, vol. 10, no. 2, 2008, pp. 131-8. |
| McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE. "Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women." Familial cancer, vol. 7, no. 4, 2008, pp. 341-5. |
| McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME, FaSTER Research Consortium. "Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study." American Journal of Obstetrics and Gynecology, vol. 199, no. 2, 2008, pp. 129.e1-6. |
| Monaghan KG, Feldman GL, Palomaki GE, Spector EB, Ashkenazi Jewish Reproductive Screening Working Group, Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. "Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population." Genet Med, vol. 10, no. 1, 2008, pp. 57-72. |
| Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME, First and Second Trimester Evaluation of Risk for Fetal Aneuploidy Research Consortium. "Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy." The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 9, 2008, pp. 3341-7. |
| Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS. "Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?." Clinical Biochemistry, vol. 41, no. 6, 2008, pp. 436-9. |
| Palomaki GE, Lambert-Messerlian GM, Canick JA. "A summary analysis of Down syndrome markers in the late first trimester." Advances in clinical chemistry, vol. 43, 2007, pp. 177-210. |
| Kavsak PA, MacRae AR, Lustig V, Newman AM, Ko DT, Tu JV, Palomaki GE, Jaffe AS. "Authors' response to Apple editorial." Clinica chimica acta; international journal of clinical chemistry, vol. 380, no. 1-2, 2007, pp. 245-6. |
| Shackleton CH, Marcos J, Palomaki GE, Craig WY, Kelley RI, Kratz LE, Haddow JE. "Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS)." American journal of medical genetics. Part A, vol. 143A, no. 18, 2007, pp. 2129-36. |
| Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. "Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction." Clinica chimica acta; international journal of clinical chemistry, vol. 380, no. 1-2, 2007, pp. 213-6. |
| Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. "Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure." Clinical Biochemistry, vol. 40, no. 5-6, 2007, pp. 326-9. |
| Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Lee J. "Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh sera." Genet Med, vol. 9, no. 7, 2007, pp. 458-63. |
| McClain MR, Palomaki GE, Haddow JE. "How reliable are BRCA1/2 mutation estimates?." Cancer Research, vol. 67, no. 10, 2007, pp. 5057; author reply 5057-8. |
| Palomaki GE, Neveux LM, Haddow JE, Wyatt P. "Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy." Prenat Diagn, vol. 27, no. 9, 2007, pp. 808-13. |
| Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS. "Long-term health outcomes associated with detectable troponin I concentrations." Clinical Chemistry, vol. 53, no. 2, 2007, pp. 220-7. |
| Craig WY, Haddow JE, Palomaki GE, Roberson M. "Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS)." Prenat Diagn, vol. 27, no. 5, 2007, pp. 409-14. |
| Gudgeon JM, McClain MR, Palomaki GE, Williams MS. "Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing." Genet Med, vol. 9, no. 7, 2007, pp. 473-8. |
| Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. "Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide." Clinical Chemistry, vol. 53, no. 12, 2007, pp. 2112-8. |
| Haddow JE, McClain MR, Palomaki GE, Hollowell JG. "Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population." The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 3, 2007, pp. 1019-22. |
| Macrae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. "Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies." Clinical Chemistry, vol. 52, no. 5, 2006, pp. 812-8. |
| Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA. "Circulating angiogenic proteins in trisomy 13." American Journal of Obstetrics and Gynecology, vol. 194, no. 1, 2006, pp. 239-45. |
| Palomaki GE, Steinort K, Knight GJ, Haddow JE. "Comparing three screening strategies for combining first- and second-trimester Down syndrome markers." Obstetrics and gynecology, vol. 107, no. 2 Pt 1, 2006, pp. 367-75. |
| Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. "Comparison of serum markers in first-trimester down syndrome screening." Obstetrics and gynecology, vol. 108, no. 5, 2006, pp. 1192-9. |
| Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS. "Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients." Clinical Chemistry, vol. 52, no. 11, 2006, pp. 2028-35. |
| Craig WY, Haddow JE, Palomaki GE, Kelley RI, Kratz LE, Shackleton CH, Marcos J, Stephen Tint G, MacRae AR, Nowaczyk MJ, Kloza EM, Irons MB, Roberson M. "Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome." Prenat Diagn, vol. 26, no. 9, 2006, pp. 842-9. |
| Ritchie RF, Palomaki GE, Neveux LM, Ledue TB, Marcovina S, Navolotskaia O. "Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 20, no. 5, 2006, pp. 218-26. |
| Ritchie RF, Palomaki GE, Neveux LM, Ledue TB, Craig WY, Marcovina S, Navolotskaia O. "Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 20, no. 5, 2006, pp. 209-17. |
| Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'donnell A, Huang T, Knight GJ, Haddow JE. "Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study." Prenat Diagn, vol. 26, no. 8, 2006, pp. 730-9. |
| Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE. "Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women." Genet Med, vol. 8, no. 3, 2006, pp. 161-8. |
| Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J. "Screening for thyroid disorders during pregnancy: results of a survey in Maine." American Journal of Obstetrics and Gynecology, vol. 194, no. 2, 2006, pp. 471-4. |
| Lambert-Messerlian GM, Eklund EE, Malone FD, Palomaki GE, Canick JA, D'Alton ME. "Stability of first- and second-trimester serum markers after storage and shipment." Prenat Diagn, vol. 26, no. 1, 2006, pp. 17-21. |
| Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. "The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction." American Heart Journal, vol. 152, no. 1, 2006, pp. 118-25. |
| Haddow JE, Palomaki GE, McClain MR. "Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges." Obstetrics and gynecology, vol. 107, no. 1, 2006, pp. 205-6; author reply 206. |
| Knight GJ, Palomaki GE, Klee GG, Schreiber WE, Cole LA. "A comparison of human chorionic gonadotropin- related components in fresh frozen serum with the proficiency testing material used by the College of American Pathologists." Archives of Pathology & Laboratory Medicine, vol. 129, no. 3, 2005, pp. 328-30. |
| McClain MR, Palomaki GE, Nathanson KL, Haddow JE. "Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications." Genet Med, vol. 7, no. 1, 2005, pp. 28-33. |
| McClain MR, Nathanson KL, Palomaki GE, Haddow JE. "An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women." Genet Med, vol. 7, no. 1, 2005, pp. 34-9. |
| Schreiber WE, Endres DB, McDowell GA, Palomaki GE, Elin RJ, Klee GG, Wang E. "Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen." Archives of Pathology & Laboratory Medicine, vol. 129, no. 3, 2005, pp. 331-7. |
| Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen AJ, Williams J, Haddow JE. "Integrated serum screening for Down syndrome in primary obstetric practice." Prenat Diagn, vol. 25, no. 12, 2005, pp. 1162-7. |
| Isman F, Palomaki GE, Natowicz MR. "Lysosomal enzymes in human peripheral blood mononuclear cells and granulocytes." Clinical Chemistry, vol. 51, no. 3, 2005, pp. 646-9. |
| Palomaki GE, Knight GJ, Neveux LM, Pandian R, Haddow JE. "Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening." Clinical Chemistry, vol. 51, no. 8, 2005, pp. 1499-504. |
| Palomaki GE, Kloza EM, Haddow JE, Williams J, Knight GJ. "Patient and health professional acceptance of integrated serum screening for Down syndrome." Seminars in Perinatology, vol. 29, no. 4, 2005, pp. 247-51. |
| Palomaki GE, Bradley LA, McDowell GA, Down Syndrome Working Group, ACMG Laboratory Quality Assurance Committee. "Technical standards and guidelines: prenatal screening for Down syndrome." Genet Med, vol. 7, no. 5, 2005, pp. 344-54. |
| Bradley LA, Palomaki GE, McDowell GA, ONTD Working Group, ACMG Laboratory Quality Assurance Committee. "Technical standards and guidelines: prenatal screening for open neural tube defects." Genet Med, vol. 7, no. 5, 2005, pp. 355-69. |
| Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ, Bradley LA, Prior TW, Feldman G, Popovich BW, Watson MS, Richards CS. "Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories." Genet Med, vol. 7, no. 6, 2005, pp. 444-53. |
| Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, Reid T, Schrag S. "The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society." Journal of medical screening, vol. 12, no. 2, 2005, pp. 60-8. |
| Palomaki GE, FitzSimmons SC, Haddow JE. "Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population." Genet Med, vol. 6, no. 5, 2004, pp. 405-14. |
| Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW. "Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel." Genet Med, vol. 6, no. 5, 2004, pp. 387-91. |
| Lambert-Messerlian G, Halliday J, Williams J, Cain R, Msall ME, Palomaki GE, Canick JA. "Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island." Journal of medical screening, vol. 11, no. 2, 2004, pp. 106-7. |
| Palomaki GE, Knight GJ, Roberson MM, Cunningham GC, Lee JE, Strom CM, Pandian R. "Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples." Clinical Chemistry, vol. 50, no. 1, 2004, pp. 182-9. |
| McClain MR, Palomaki GE, Haddow JE. "Is first trimester measurement of sex hormone binding globulin a possible screening test for gestational diabetes mellitus." American Journal of Obstetrics and Gynecology, vol. 190, no. 6, 2004, pp. 1808-9;author reply 1809. |
| Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian R. "Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester." Clinical Chemistry, vol. 50, no. 10, 2004, pp. 1804-8. |
| Palomaki GE. "Prenatal screening for cystic fibrosis: an early report card." Genet Med, vol. 6, no. 3, 2004, pp. 115-6. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. "Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 18, no. 2, 2004, pp. 148-52. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 18, no. 2, 2004, pp. 139-47. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. "Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 18, no. 1, 2004, pp. 9-13. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 18, no. 1, 2004, pp. 1-8. |
| Pandian R, Cole LA, Palomaki GE. "Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening." Clinical Chemistry, vol. 50, no. 8, 2004, pp. 1433-5. |
| Ritchie RF, Palomaki G. "Selecting clinically relevant populations for reference intervals." Clinical chemistry and laboratory medicine : CCLM / FESCC, vol. 42, no. 7, 2004, pp. 702-9. |
| Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ. "The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy." Journal of medical screening, vol. 11, no. 4, 2004, pp. 170-4. |
| Palomaki GE, Bradley LA, Richards CS, Haddow JE. "Analytic validity of cystic fibrosis testing: a preliminary estimate." Genet Med, vol. 5, no. 1, 2003, pp. 15-20. |
| Palomaki GE, Williams J, Haddow JE. "Comparing the observed and predicted effectiveness of folic acid fortification in preventing neural tube defects." Journal of medical screening, vol. 10, no. 1, 2003, pp. 52-3. |
| Wald NJ, Morris JK, Rodeck CH, Haddow JE, Palomaki GE. "Cystic fibrosis: selecting the prenatal screening strategy of choice." Prenat Diagn, vol. 23, no. 6, 2003, pp. 474-83. |
| Knight GJ, Palomaki GE. "Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome." Clinics in laboratory medicine, vol. 23, no. 2, 2003, pp. 531-51, xi. |
| Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW. "Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing." Genet Med, vol. 5, no. 6, 2003, pp. 440-3. |
| Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, Palomaki GE, Bianchi DW. "Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy." Clinical Chemistry, vol. 49, no. 2, 2003, pp. 239-42. |
| Haddow JE, Palomaki GE, McClain M, Craig W. "Hereditary haemochromatosis and hepatocellular carcinoma in males: a strategy for estimating the potential for primary prevention." Journal of medical screening, vol. 10, no. 1, 2003, pp. 11-3. |
| Palomaki GE, Neveux LM, Knight GJ, Haddow JE. "Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers." Prenat Diagn, vol. 23, no. 3, 2003, pp. 243-7. |
| Palomaki GE, Bradley LA, Knight GJ, Craig WY, Haddow JE. "Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome." Journal of medical screening, vol. 9, no. 1, 2002, pp. 43-4. |
| Burke W, Atkins D, Gwinn M, Guttmacher A, Haddow J, Lau J, Palomaki G, Press N, Richards CS, Wideroff L, Wiesner GL. "Genetic test evaluation: information needs of clinicians, policy makers, and the public." American Journal of Epidemiology, vol. 156, no. 4, 2002, pp. 311-8. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for serum iron and transferrin saturation: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 16, no. 5, 2002, pp. 246-52. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 16, no. 5, 2002, pp. 237-45. |
| Richards CS, Bradley LA, Amos J, Allitto B, Grody WW, Maddalena A, McGinnis MJ, Prior TW, Popovich BW, Watson MS, Palomaki GE. "Standards and guidelines for CFTR mutation testing." Genet Med, vol. 4, no. 5, 2002, pp. 379-91. |
| Haddow JE, Palomaki GE, Williams J. "Thyroid-stimulating-hormone concentrations and risk of hypothyroidism." The Lancet, vol. 360, no. 9350, 2002, pp. 2081-2; author reply 2082. |
| Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. "Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians." Genet Med, vol. 4, no. 2, 2002, pp. 90-4. |
| Steele BW, Wang E, Palomaki GE, Klee GG, Elin RJ, Soldin SJ, Witte DL. "An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study." Archives of Pathology & Laboratory Medicine, vol. 125, no. 6, 2001, pp. 729-35. |
| Knight GJ, Palomaki GE, Neveux LM, Haddow JE, Lambert-Messerlian GM. "Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening." Journal of medical screening, vol. 8, no. 1, 2001, pp. 2-7. |
| Allan WC, Timothy K, Vincent GM, Palomaki GE, Neveux LM, Haddow JE. "Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population." Journal of medical screening, vol. 8, no. 4, 2001, pp. 173-7. |
| Allan WC, Timothy K, Vincent GM, Palomaki GE, Neveux LM, Haddow JE. "Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting." Journal of medical screening, vol. 8, no. 4, 2001, pp. 178-82. |
| Steele BW, Wang E, Palomaki G, Klee GG, Elin RJ, Witte DL. "Sources of variability: a College of American Pathologists Therapeutic Drug Monitoring study." Archives of Pathology & Laboratory Medicine, vol. 125, no. 2, 2001, pp. 183-90. |
| Palomaki GE, Neveux LM. "Using multiples of the median to normalize serum protein measurements." Clinical chemistry and laboratory medicine : CCLM / FESCC, vol. 39, no. 11, 2001, pp. 1137-45. |
| Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, Faix JD, Klein RZ. "Maternal thyroid deficiency and pregnancy complications: implications for population screening." Journal of medical screening, vol. 7, no. 3, 2000, pp. 127-30. |
| Mitchell ML, Hermos RJ, Larson CA, Palomaki GE, Haddow JE. "Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis." Diabetes Care, vol. 23, no. 11, 2000, pp. 1705-6. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. "Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 14, no. 6, 2000, pp. 265-70. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 14, no. 6, 2000, pp. 284-92. |
| Lambert-Messerlian GM, Palomaki GE, Canick JA. "Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects." Prenat Diagn, vol. 20, no. 8, 2000, pp. 680-2. |
| Palomaki GE, Haddow JE. "Age-related prevalence of down syndrome." American Journal of Obstetrics and Gynecology, vol. 180, no. 6 Pt 1, 1999, pp. 1597-8. |
| Haddow JE, Bradley LA, Palomaki GE, Doherty RA, Bernhardt BA, Brock DJ, Cheuvront B, Cunningham GC, Donnenfeld AE, Erickson JL, Erlich HA, Ferrie RM, FitzSimmons SC, Greene MF, Grody WW, Haddow PK, Harris H, Holmes LB, Howell RR, Katz M, Klinger KW, Kloza EM, LeFevre ML, Little S, Loeben G, McGovern M, Pyeritz RE, Rowley PT, Saiki RK, Short MP, Tabone J, Wald NJ, Wilker NL, Witt DR. "Issues in implementing prenatal screening for cystic fibrosis: results of a working conference." Genet Med, vol. 1, no. 4, 1999, pp. 129-35. |
| Haddow JE, Bradley LA, Palomaki GE, Doherty RA. "Issues in implementing prenatal screening for cystic fibrosis: results of a working conference." Journal of medical screening, vol. 6, no. 2, 1999, pp. 60-6. |
| Bradley LA, Palomaki GE, Knight GJ, Haddow JE, Opitz JM, Irons M, Kelley RI, Tint GS. "Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses." American journal of medical genetics, vol. 82, no. 4, 1999, pp. 355-8. |
| Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ. "Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child." New England Journal of Medicine, vol. 341, no. 8, 1999, pp. 549-55. |
| Palomaki GE, Williams JR, Haddow JE. "Prenatal screening for open neural-tube defects in Maine." New England Journal of Medicine, vol. 340, no. 13, 1999, pp. 1049-50. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. "Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 13, no. 6, 1999, pp. 280-6. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 13, no. 6, 1999, pp. 273-9. |
| Saller DN Jr, Canick JA, Blitzer MG, Palomaki GE, Schwartz S, Blakemore KJ, Haddow JE. "Second-trimester maternal serum analyte levels associated with fetal trisomy 13." Prenat Diagn, vol. 19, no. 9, 1999, pp. 813-6. |
| Palomaki GE, Neveux LM, Haddow JE. "Current Down syndrome risk estimates are reliable." American Journal of Obstetrics and Gynecology, vol. 178, no. 4, 1998, pp. 871-2. |
| Knight GJ, Palomaki GE, Neveux LM, Fodor KK, Haddow JE. "hCG and the free beta-subunit as screening tests for Down syndrome." Prenat Diagn, vol. 18, no. 3, 1998, pp. 235-45. |
| Bradley LA, Johnson DD, Palomaki GE, Haddow JE, Robertson NH, Ferrie RM. "Hereditary haemochromatosis mutation frequencies in the general population." Journal of medical screening, vol. 5, no. 1, 1998, pp. 34-6. |
| Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. "Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies." Clinical Chemistry, vol. 44, no. 11, 1998, pp. 2301-6. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. "Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature." Journal of clinical laboratory analysis, vol. 12, no. 6, 1998, pp. 371-7. |
| Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. "Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort." Journal of clinical laboratory analysis, vol. 12, no. 6, 1998, pp. 363-70. |
| Haddow JE, Palomaki GE, Bradley LA, Doherty RA. "Screening for cystic fibrosis." JAMA, vol. 279, no. 14, 1998, pp. 1068; author reply 1069. |
| Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A. "Screening of maternal serum for fetal Down's syndrome in the first trimester." New England Journal of Medicine, vol. 338, no. 14, 1998, pp. 955-61. |
| Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. "Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A." Journal of medical screening, vol. 5, no. 3, 1998, pp. 115-9. |
| Cole LA, Acuna E, Isozaki T, Palomaki GE, Bahado-Singh RO, Mahoney MO. "Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies." Prenat Diagn, vol. 17, no. 12, 1997, pp. 1125-33. |
| Cole LA, Kellner LH, Isozaki T, Palomaki GE, Iles RK, Walker RP, Ozaki M, Canick JA. "Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies." Prenat Diagn, vol. 17, no. 7, 1997, pp. 607-14. |
| Kellner LH, Canick JA, Palomaki GE, Neveux LM, Saller DN Jr, Walker RP, Osathanondh R, Bombard AT. "Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome." Prenat Diagn, vol. 17, no. 12, 1997, pp. 1135-41. |
| Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, donhowe JM. "Maternal serum screening for Down syndrome in the United States: a 1995 survey." American Journal of Obstetrics and Gynecology, vol. 176, no. 5, 1997, pp. 1046-51. |
| Isozaki T, Palomaki GE, Bahado-Singh RO, Cole LA. "Screening for Down syndrome pregnancy using beta-core fragment: prospective study." Prenat Diagn, vol. 17, no. 5, 1997, pp. 407-13. |
| Cole LA, Jacobs M, Isozaki T, Palomaki GE, Bahado-Singh RO, Mahoney MJ. "Screening for Down syndrome using urine hCG free beta-subunit in the second trimester of pregnancy." Prenat Diagn, vol. 17, no. 12, 1997, pp. 1107-11. |
| Star J, Canick JA, Palomaki GE, Carpenter MW, Saller DN Jr, Sung CJ, Tumber MB, Coustan DR. "The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes." Prenat Diagn, vol. 17, no. 2, 1997, pp. 149-54. |
| Bradley LA, Canick JA, Palomaki GE, Haddow JE. "Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency." American Journal of Obstetrics and Gynecology, vol. 176, no. 3, 1997, pp. 531-5. |
| Palomaki GE, Neveux LM, Haddow JE. "Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?." Journal of medical screening, vol. 3, no. 1, 1996, pp. 12-7. |
| Knight GJ, Haddow JE, Palomaki GE, Donhowe JM, Witte DL. "Computer software programs and Down's syndrome risk calculations." The Lancet, vol. 347, no. 9014, 1996, pp. 1553. |
| Doherty RA, Palomaki GE, Kloza EM, Erickson JL, Haddow JE. "Couple-based prenatal screening for cystic fibrosis in primary care settings." Prenat Diagn, vol. 16, no. 5, 1996, pp. 397-404. |
| Cole L, Isozaki T, Palomaki G, Canick J, Iles R, Kellner L, Saller D, Cuckle H. "Detection of beta-core fragment in second trimester Down's syndrome pregnancies." Early human development, vol. 47 Suppl, 1996, pp. S47-8. |
| Palomaki GE. "Down's syndrome epidemiology and risk estimation." Early human development, vol. 47 Suppl, 1996, pp. S19-26. |
| Haddow JE, Palomaki GE. "Down's syndrome screening." The Lancet, vol. 347, no. 9015, 1996, pp. 1625; author reply 1625-6. |
| Palomaki GE, Haddow JE. "Gestational dating and Down's syndrome screening." Annals of clinical biochemistry, vol. 33 ( Pt 4), 1996, pp. 359-61. |
| Haddow JE, Palomaki GE, Knight GJ, Williams J, Chilmonczyk BA. "Intervening to reduce environmental tobacco smoke exposure in infants." Pediatrics, vol. 98, no. 3 Pt 1, 1996, pp. 513. |
| Lambert-Messerlian GM, Canick JA, Palomaki GE. "Maternal serum total activin A in pregnancies affected with fetal Down's syndrome." Journal of medical screening, vol. 3, no. 4, 1996, pp. 217. |
| Neveux LM, Palomaki GE, Knight GJ, Haddow JE. "Multiple marker screening for Down syndrome in twin pregnancies." Prenat Diagn, vol. 16, no. 1, 1996, pp. 29-34. |
| Palomaki GE, Haddow JE. "Nicked free beta-subunit and Down syndrome screening." American Journal of Obstetrics and Gynecology, vol. 175, no. 4 Pt 1, 1996, pp. 1075. |
| Bradley LA, Haddow JE, Palomaki GE. "Population screening for haemochromatosis: a unifying analysis of published intervention trials." Journal of medical screening, vol. 3, no. 4, 1996, pp. 178-84. |
| Bradley LA, Haddow JE, Palomaki GE. "Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands." Journal of medical screening, vol. 3, no. 4, 1996, pp. 171-7. |
| Palomaki GE, Haddow JE, Beauregard LJ. "Prenatal screening for Down's syndrome in Maine, 1980 to 1993." New England Journal of Medicine, vol. 334, no. 21, 1996, pp. 1409-10. |
| Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. "Refinements in managing maternal weight adjustment for interpreting prenatal screening results." Prenat Diagn, vol. 16, no. 12, 1996, pp. 1115-9. |
| Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. "Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy." Journal of medical screening, vol. 3, no. 2, 1996, pp. 58-62. |
| Haddow JE, Palomaki GE. "Similarities in women's decision-making in the U.S. and U.K. during prenatal screening for Down's syndrome." Prenat Diagn, vol. 16, no. 12, 1996, pp. 1161-2. |
| Craig WY, Poulin SE, Neveux LM, Palomaki GE, Dostal-Johnson DA, Ledue TB, Ritchie RF. "Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes." Journal of autoimmunity, vol. 8, no. 5, 1995, pp. 713-26. |
| Palomaki GE, Neveux LM, Haddow JE. "Are DADs (discriminant aneuploidy detection) as good as MOMs (multiples of the median)?." American Journal of Obstetrics and Gynecology, vol. 173, no. 6, 1995, pp. 1895-7. |
| Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S. "Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements." American Journal of Obstetrics and Gynecology, vol. 173, no. 6, 1995, pp. 1742-8. |
| Palomaki GE, Haddow JE. "Can the risk for Down syndrome be reliably modified by second-trimester ultrasonography?." American Journal of Obstetrics and Gynecology, vol. 173, no. 5, 1995, pp. 1639-40. |
| Wald NJ, Kennard A, Watt H, Haddow JE, Palomaki GE, Knight G, Canick JA. "Decision analysis and screening for Down's syndrome. Testing should be in all women." BMJ, vol. 311, no. 7016, 1995, pp. 1372-3. |
| Haddow JE, Palomaki GE, Knight GJ. "Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening." Journal of medical screening, vol. 2, no. 1, 1995, pp. 28-30. |
| Haddow JE, Palomaki GE. "Is maternal obesity a risk factor for open neural tube defects?." American Journal of Obstetrics and Gynecology, vol. 172, no. 1 Pt 1, 1995, pp. 245-7. |
| Craig WY, Poulin SE, Palomaki GE, Neveux LM, Ritchie RF, Ledue TB. "Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 6, 1995, pp. 733-9. |
| Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, Saller DN Jr, Blitzer MG, Dickerman LH, Fisher R. "Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin." Prenat Diagn, vol. 15, no. 8, 1995, pp. 713-23. |
| Canick JA, Kellner LH, Saller DN Jr, Palomaki GE, Walker RP, Osathanondh R. "Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy." Prenat Diagn, vol. 15, no. 8, 1995, pp. 739-44. |
| Haddow JE, Palomaki GE, Sepulveda D. "Smoking cessation counseling during routine public prenatal care." American Journal of Public Health, vol. 85, no. 10, 1995, pp. 1451-2. |
| Palomaki GE, Williams J, Haddow JE, Natowicz MR. "Tay-Sachs disease in persons of French-Canadian heritage in northern New England." American journal of medical genetics, vol. 56, no. 4, 1995, pp. 409-12. |
| Haddow JE, Palomaki GE. "Use of personal records for research purposes. Restrictions unnecessary and obstructive." BMJ, vol. 310, no. 6974, 1995, pp. 258. |
| Palomaki GE, Bradley LA, Haddow JE. "A new approach to analysing fluorescence in situ hybridisation data for rapid detection of aneuploidy in amniocytes." Journal of medical screening, vol. 1, no. 2, 1994, pp. 96-7. |
| Palomaki GE, Haddow JE. "Comparison of two Down syndrome screening strategies for women aged 35 and older." Prenat Diagn, vol. 14, no. 9, 1994, pp. 898-9. |
| Johnson AM, Ledue TB, Palomaki GE, Craig WY. "Effect of storage at -70 degrees C on immunoturbidimetric assays for apolipoproteins A-I and B." Clinica chimica acta; international journal of clinical chemistry, vol. 231, no. 1, 1994, pp. 89-94. |
| Palomaki GE, Knight GJ, Haddow JE. "Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome." Prenat Diagn, vol. 14, no. 1, 1994, pp. 65-8. |
| Rose NC, Palomaki GE, Haddow JE, Goodman DB, Mennuti MT. "Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older." American Journal of Obstetrics and Gynecology, vol. 170, no. 4, 1994, pp. 1073-8; discussion 1078-80. |
| Haddow JE, Palomaki GE. "Multiparity and Down's syndrome." The Lancet, vol. 344, no. 8927, 1994, pp. 956. |
| Palomaki GE. "Population based prenatal screening for the fragile X syndrome." Journal of medical screening, vol. 1, no. 1, 1994, pp. 65-72. |
| Doherty RA, Palomaki GE, Kloza EM, Erickson JL, Dostal DA, Haddow JE. "Prenatal screening for cystic fibrosis." The Lancet, vol. 343, no. 8890, 1994, pp. 172. |
| Haddow JE, Knight GJ, Palomaki GE. "Prenatal ultrasound screening and perinatal outcome." New England Journal of Medicine, vol. 330, no. 8, 1994, pp. 571; author reply 571-2. |
| Donnenfeld AE, Carlson DE, Palomaki GE, Librizzi RJ, Weiner S, Platt LD. "Prospective multicenter study of second-trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies." Obstetrics and gynecology, vol. 84, no. 5, 1994, pp. 844-7. |
| Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. "Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening." New England Journal of Medicine, vol. 330, no. 16, 1994, pp. 1114-8. |
| Haddow JE, Knight GJ, Palomaki GE, Neveux LM, Chilmonczyk BA. "Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations." Clinical Chemistry, vol. 40, no. 4, 1994, pp. 562-4. |
| Rose NC, Canick JA, Knight GJ, Pulkkinen A, Tumber MB, Mennuti MT, Palomaki GE. "Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?." Prenat Diagn, vol. 14, no. 10, 1994, pp. 947-51. |
| Saller DN Jr, Canick JA, Palomaki GE, Knight GJ, Haddow JE. "Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects." Obstetrics and gynecology, vol. 84, no. 5, 1994, pp. 852-5. |
| Haddow JE, Knight GJ, Palomaki GE. "Antenatal screening for Down's syndrome. Performance of different markers remains confused." BMJ, vol. 307, no. 6905, 1993, pp. 679-80. |
| Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, Pulkkinen AJ, Haddow JE. "Association between exposure to environmental tobacco smoke and exacerbations of asthma in children." New England Journal of Medicine, vol. 328, no. 23, 1993, pp. 1665-9. |
| Wald NJ, Smith D, Kennard A, Palomaki GE, Salonen R, Holzgreve W, Pejtsik B, Coombes EJ, Mancini G, MacRae AR. "Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome." British journal of obstetrics and gynaecology, vol. 100, no. 5, 1993, pp. 430-5. |
| Palomaki GE, Knight GJ, Haddow JE. "Calculating amniotic fluid alpha-fetoprotein median values in the first trimester." Prenat Diagn, vol. 13, no. 9, 1993, pp. 887-9. |
| Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. "Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening." Obstetrics and gynecology, vol. 81, no. 5 ( Pt 1), 1993, pp. 675-8. |
| Palomaki GE, Haddow JE. "Is it time for population-based prenatal screening for fragile-X?." The Lancet, vol. 341, no. 8841, 1993, pp. 373-4. |
| Palomaki GE, Knight GJ, Haddow JE. "Is MoM bashing justified?." The American Journal of Human Genetics, vol. 53, no. 3, 1993, pp. 777-81. |
| Palomaki GE, Knight GJ, McCarthy J, Haddow JE, Eckfeldt JH. "Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey." American Journal of Obstetrics and Gynecology, vol. 169, no. 6, 1993, pp. 1558-62. |
| Knight GJ, Palomaki GE, Haddow JE, Miller W, Bersinger NA, Schneider H. "Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy." Prenat Diagn, vol. 13, no. 3, 1993, pp. 222-3. |
| Donnenfeld AE, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. "Simultaneous fetal and maternal cotinine levels in pregnant women smokers." American Journal of Obstetrics and Gynecology, vol. 168, no. 3 Pt 1, 1993, pp. 781-2. |
| Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, Spear NH. "The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program." Diabetes Care, vol. 16, no. 2, 1993, pp. 450-5. |
| Ledue TB, Neveux LM, Palomaki GE, Ritchie RF, Craig WY. "The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response." Clinica chimica acta; international journal of clinical chemistry, vol. 223, no. 1-2, 1993, pp. 73-82. |
| Wald N, Hackshaw A, Haddow JE, Palomaki GE, Knight GJ. "Use of free beta-hCG in Down's syndrome screening." Annals of clinical biochemistry, vol. 30 ( Pt 5), 1993, pp. 512-8. |
| Haddow JE, Palomaki GE, Holman MS. "Young maternal age and smoking during pregnancy as risk factors for gastroschisis." Teratology, vol. 47, no. 3, 1993, pp. 225-8. |
| Chilmonczyk BA, Palomaki GE, Knight GJ, Williams J, Haddow JE. "An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy." American journal of diseases of children (1960), vol. 146, no. 3, 1992, pp. 357-60. |
| Haddow JE, Holman MS, Palomaki GE. "Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?." Prenat Diagn, vol. 12, no. 1, 1992, pp. 65-8. |
| Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN Jr, Bowers GB. "Prenatal screening for Down's syndrome with use of maternal serum markers." New England Journal of Medicine, vol. 327, no. 9, 1992, pp. 588-93. |
| Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN Jr, Panizza DS. "Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin." Prenat Diagn, vol. 12, no. 11, 1992, pp. 925-30. |
| Haddow JE, Knight GJ, Kloza EM, Palomaki GE, Wald NJ. "Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery." British journal of obstetrics and gynaecology, vol. 98, no. 9, 1991, pp. 859-65. |
| Haddow JE, Rote NS, Dostal-Johnson D, Palomaki GE, Pulkkinen AJ, Knight GJ. "Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester." American Journal of Obstetrics and Gynecology, vol. 165, no. 5 Pt 1, 1991, pp. 1308-12. |
| Rose NC, Haddow JE, Palomaki GE, Knight GJ. "Self-rated physical activity level during the second trimester and pregnancy outcome." Obstetrics and gynecology, vol. 78, no. 6, 1991, pp. 1078-80. |
| Craig WY, Palomaki GE, Johnson AM, Haddow JE. "Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis." Pediatrics, vol. 85, no. 2, 1990, pp. 155-8. |
| Chilmonczyk BA, Knight GJ, Palomaki GE, Pulkkinen AJ, Williams J, Haddow JE. "Environmental tobacco smoke exposure during infancy." American Journal of Public Health, vol. 80, no. 10, 1990, pp. 1205-8. |
| Johnson AM, Palomaki GE, Haddow JE. "Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study." American Journal of Obstetrics and Gynecology, vol. 162, no. 2, 1990, pp. 328-31. |
| Palomaki GE, Knight GJ, Holman MS, Haddow JE. "Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey." American Journal of Obstetrics and Gynecology, vol. 162, no. 2, 1990, pp. 317-21. |
| Haddow JE, Palomaki GE, Knight GJ, Canick JA, Wald NJ, Cuckle HS. "Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome." American Journal of Obstetrics and Gynecology, vol. 163, no. 4 Pt 1, 1990, pp. 1372-4. |
| Canick JA, Palomaki GE, Osathanondh R. "Prenatal screening for trisomy 18 in the second trimester." Prenat Diagn, vol. 10, no. 8, 1990, pp. 546-8. |
| Canick JA, Knight GJ, Palomaki GE, Haddow JE. "Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida." Prenat Diagn, vol. 10, no. 11, 1990, pp. 733-7. |
| Johnson AM, Palomaki GE, Haddow JE. "The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study." American Journal of Obstetrics and Gynecology, vol. 163, no. 1 Pt 1, 1990, pp. 9-11. |
| Cuckle HS, Wald NJ, Densem JW, Royston P, Knight GJ, Haddow JE, Palomaki GE. "The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels." British journal of obstetrics and gynaecology, vol. 97, no. 3, 1990, pp. 272-4. |
| Mahoney RJ, Ault KA, Given SR, Adams RJ, Breggia AC, Paris PA, Palomaki GE, Hitchcox SA, White BW, Himmelfarb J. "The flow cytometric crossmatch and early renal transplant loss." Transplantation, vol. 49, no. 3, 1990, pp. 527-35. |
| Goldfine C, Knight GJ, Haddow JE, Palomaki GE. "Amniotic fluid acetylcholinesterase measurements: comparing immunochemical and polyacrylamide gel techniques." Prenat Diagn, vol. 9, no. 3, 1989, pp. 167-72. |
| Goldfine C, Haddow JE, Knight GJ, Palomaki GE. "Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis." Prenat Diagn, vol. 9, no. 10, 1989, pp. 697-700. |
| Craig WY, Palomaki GE, Haddow JE. "Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data." BMJ, vol. 298, no. 6676, 1989, pp. 784-8. |
| Knight GJ, Palomaki GE, Lea DH, Haddow JE. "Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay." Clinical Chemistry, vol. 35, no. 6, 1989, pp. 1036-9. |
| Wald NJ, Cuckle HS, Sneddon J, Haddow JE, Palomaki GE. "Screening for Down syndrome." The American Journal of Human Genetics, vol. 44, no. 4, 1989, pp. 586-90. |
| Osathanondh R, Canick JA, Abell KB, Stevens LD, Palomaki GE, Knight GJ, Haddow JE. "Second trimester screening for trisomy 21." The Lancet, vol. 2, no. 8653, 1989, pp. 52. |
| Haddow JE, Knight GJ, Palomaki GE, Haddow PK. "Estimating fetal morbidity and mortality resulting from cigarette smoke exposure by measuring cotinine levels in maternal serum." Progress in clinical and biological research, vol. 281, 1988, pp. 289-300. |
| Cuckle HS, Wald NJ, Barkai G, Fuhrmann W, Altland K, Brambati B, Knight G, Palomaki G, Haddow JE, Canick J. "First-trimester biochemical screening for Down syndrome." The Lancet, vol. 2, no. 8615, 1988, pp. 851-2. |
| Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. "Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome." British journal of obstetrics and gynaecology, vol. 95, no. 4, 1988, pp. 330-3. |
| Greene MF, Haddow JE, Palomaki GE, Knight GJ. "Maternal serum alpha-fetoprotein levels in diabetic pregnancies." The Lancet, vol. 2, no. 8606, 1988, pp. 345-6. |
| Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. "Maternal serum screening for Down's syndrome in early pregnancy." BMJ, vol. 297, no. 6653, 1988, pp. 883-7. |
| Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, Knight GJ, Palomaki GE. "Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome." British journal of obstetrics and gynaecology, vol. 95, no. 4, 1988, pp. 334-41. |
| Palomaki GE, Hill LE, Knight GJ, Haddow JE, Carpenter M. "Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele." Obstetrics and gynecology, vol. 71, no. 6 Pt 1, 1988, pp. 906-9. |
| Haddow JE, Knight GJ, Palomaki GE, McCarthy JE. "Second-trimester serum cotinine levels in nonsmokers in relation to birth weight." American Journal of Obstetrics and Gynecology, vol. 159, no. 2, 1988, pp. 481-4. |
| Knight GJ, Palomaki GE, Haddow JE. "Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome." Clinical obstetrics and gynecology, vol. 31, no. 2, 1988, pp. 306-27. |
| Haddow JE, Palomaki GE, Knight GJ. "Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?." Obstetrics and gynecology, vol. 70, no. 1, 1987, pp. 26-8. |
| Haddow JE, Knight GJ, Palomaki GE, Kloza EM, Wald NJ. "Cigarette consumption and serum cotinine in relation to birthweight." British journal of obstetrics and gynaecology, vol. 94, no. 7, 1987, pp. 678-81. |
| Palomaki GE, Haddow JE. "Maternal serum alpha-fetoprotein, age, and Down syndrome risk." American Journal of Obstetrics and Gynecology, vol. 156, no. 2, 1987, pp. 460-3. |
| Knight GJ, Haddow J, Palomaki GE, Haddow JE. "Selection and validation of alpha-fetoprotein assay kits for the screening of Down syndrome." American Journal of Obstetrics and Gynecology, vol. 156, no. 6, 1987, pp. 1557-9. |
| Haddow JE, Hill LE, Palomaki GE, Knight GJ. "Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death." Prenat Diagn, vol. 7, no. 6, 1987, pp. 401-6. |
| Haddow JE, Knight GJ, Kloza EM, Palomaki GE. "Alpha-fetoprotein, vaginal bleeding and pregnancy risk." British journal of obstetrics and gynaecology, vol. 93, no. 6, 1986, pp. 589-93. |
| Palomaki GE. "Collaborative study of Down syndrome screening using maternal serum alpha-fetoprotein and maternal age." The Lancet, vol. 2, no. 8521-22, 1986, pp. 1460. |
| Haddow JE, Palomaki GE, Wald NJ, Cuckle HS. "Maternal serum alpha-fetoprotein screening for Down syndrome and repeat testing." The Lancet, vol. 2, no. 8521-22, 1986, pp. 1460. |
| Knight GJ, Palomaki GE, Haddow JE. "Maternal serum alpha-fetoprotein: a problem with a test kit." New England Journal of Medicine, vol. 314, no. 8, 1986, pp. 516. |
| Haddow JE, Palomaki GE, Knight GJ. "Use of serum cotinine to assess the accuracy of self reported non-smoking." British medical journal (Clinical research ed.), vol. 293, no. 6557, 1986, pp. 1306. |
| Palomaki GE, Knight GJ, Kloza EM, Haddow JE. "Maternal weight adjustment and low serum alpha-fetoprotein values." The Lancet, vol. 1, no. 8426, 1985, pp. 468. |
| Keilson L, Lambert D, Fabian D, Thebarge J, Ackerson T, Palomaki G, Turgeon W. "Screening for hypothermia in the ambulatory elderly. The Maine experience." JAMA, vol. 254, no. 13, 1985, pp. 1781-4. |
| Haddow JE, Palomaki G, Kloza EM, Knight GJ. "Does smoking influence serum alpha-fetoprotein levels in mid-trimester pregnancies?." British journal of obstetrics and gynaecology, vol. 91, no. 12, 1984, pp. 1188-91. |
| Mahoney RJ, Gazit E, MacCarthy-Shanley K, Martin-Alosco S, Palomaki GE, Smith DE, Yunis EJ. "Alloantisera detect HLA-A-B-C and non-HLA differentiation antigens on human thymocytes." The Journal of Immunology, vol. 129, no. 6, 1982, pp. 2630-5. |
| Year | Degree | Institution |
|---|---|---|
| 2011 | PhD | Queen Mary University of London |
| 1973 | BS | University of New Hampshire |
1987-Present Member, New England Regional Genetics Group
1992-2005 Consultant, Therapeutic Drug Monitoring/Endocrine Resource Committee, College of American Pathologists
1996-Present Member, American College of Medical Genetics
1997-Present Co-Chair, Data Committee, New England Regional Genetics Group
1997-Present Member, Subcommittee on AFP and Related Analytes, American College of Medical Genetics
1998-2000 Co-Director, New England Regional Genetics Group
2001-Present Member, Quality Assurance Committee, American College of Medical Genetics
2010-Present Consultant, Biochemical and Molecular Genetics Resource Committee, College of American Pathologists
2011-Present Member, Evidence Evaluation Methods Workgroup, Health Resources and Health Services Administration (HRSA), US Department of Health and Human Services
2010-Present Member, Ad Hoc Committee on the Value of Genetic Diagnosis, American College of Medical Genetics
